Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History
Bought
Maintained
Sold
Other funds holding CNBS
TI
OMC
MFG
FLP
AWM
Citadel Advisors's CNBS Position: Q2 2026 in Review
Citadel Advisors increased its Amplify Seymour Cannabis ETF (CNBS) stake by 27% in Q2 2026, buying an estimated $109K and bringing the position to 18,751 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9627.
Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.
- Citadel Advisors held 18,751 shares of Amplify Seymour Cannabis ETF worth $548K as of Q2 2026.
- Citadel Advisors bought 3,963 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $109K.
- Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9627 holding.
- Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 6 quarters since.
- 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.